Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phagolysosome is a specialized intracellular organelle generated by fusion of the phagosome (engulfed pathogen/particle-containing vesicle) with the lysosome. Its internal pH becomes highly acidic (typically pH 4.5-5.5) due to proton pumping by V-ATPase complexes, which is essential for activating digestive enzymes (hydrolases) and for optimal antimicrobial activity. Acidification enables enzymatic degradation of pathogens and cell debris, hydrolytic breakdown of proteins, and sometimes acts directly as an antimicrobial trigger. Proper regulation of phagolysosome pH is necessary for effective innate immune responses, antigen processing, and presentation, while certain pathogens manipulate or adapt to phagolysosomal pH for intracellular survival. Drugs do not directly target phagolysosome pH, but its alteration can be instrumental in studying cell-autonomous immunity and pathogen-host interactions.
if drugs were to target this, it would be by modulating proton pump activity, e.g. V-ATPase inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phagolysosome pH.